Abstract: An apparatus and method for displaying digital content onto a vehicle, the apparatus including a foam apparatus, a sensor configured to detect vehicle dimension data, at least a processor and a memory communicatively connected to the at least a processor, wherein the memory contains instructions configuring the at least a processor to receive the vehicle dimension data, calculate a concentration requirement based on the vehicle dimension data, transmit the concentration requirement to the foam apparatus, wherein the foam apparatus is configured to disperse foam onto the vehicle based on the concentration requirement, and a display device including a digital content projector, wherein the display device is configured to display a plurality of digital content onto the foam dispersed onto the vehicle.

Abstract: An apparatus and a method for vehicle profiling. The apparatus includes at least a sensor, wherein the at least a sensor is configured to capture vehicle data of a vehicle, at least a processor and a memory communicatively connected to the at least processor, the memory contains instructions configuring the at least processor to receive the vehicle data from the at least a sensor, generate a graphic model of the vehicle as a function of the vehicle data, determine a vehicle status as a function of the vehicle data, classify the vehicle status and the vehicle data into one or more vehicle status groups and generate a vehicle report as a function of the one or more vehicle status groups.

Abstract: An apparatus for image projection is disclosed herein. In some embodiments, an apparatus may include an image projection device, a sealed housing, and a cooling system. A sealed housing may be configured to protect an image projection device from a foreign element. A sealed housing may include an image output window. A cooling system may include a cooling pad and a coolant reservoir. A cooling system may be configured to modulate the temperature of the image projection device.

Abstract: Aspects of the disclosure provide controlling an autonomous vehicle. For example, a first trajectory generated by a first planning system may be received. A portion of the first trajectory may be input into a second planning system. A second trajectory generated by the second planning system based on the portion of the first trajectory may be received. The second trajectory may be used to determine whether to validate the first trajectory, and when the second trajectory is determined to be validated, the autonomous vehicle may be enabled to be controlled based on the first trajectory.

Abstract: An apparatus for a credential verification system with a water-resistant and tamper-proof housing, wherein the apparatus includes a credential verification system including image capturing devices, and a housing containing a multi-layer enclosure containing a first set of vents, a bottom plate attached to the multi-layer enclosure, wherein the bottom plate contains a second set of vents, an opening plate configured to mount the credential verification system, wherein the opening plate includes a mechanical interface configured to mechanically connect the opening plate to the bottom plate and a locking mechanism configured to removably attach the opening plate to the multi-layer enclosure and the bottom plate, and a view window, wherein the credential verification system is configured to identify a credential through the view window using the plurality of image capturing device, and an airflow is directed from the second set of vents to the first set of vents.

Abstract: A tie fastener apparatus for attaching railroad ties to a superstructure. The apparatus comprises a threaded hook bolt, including a hook with a hook end to engage the underside of a flange of a superstructure beam. The apparatus further includes a metal member for engaging plural ties, the metal member including a tie fastener hole at plural locations, and a nut for fastening a threaded end of the threaded hook bolt for installation when the threaded hook bolt is passed through the bolt hole and optionally a washer. When the threaded hook bolt is installed, including passing a threaded end of the threaded hook bolt through the bolt hole and fastening with the nut, the hook engages the superstructure. The apparatus is installed from above the superstructure without drilling holes in ties or the superstructure, or requiring manned installation from below the superstructure.

Abstract: Methods, system and apparatus are disclosed, including a tie fastener apparatus for attaching railroad ties to a superstructure. The apparatus comprises a threaded hook bolt, including a hook with a hook end to engage the underside of a flange of a superstructure beam. The apparatus further comprises: a metal member for engaging plural ties, the metal member including a tie fastener hole at plural locations, and a nut for fastening a threaded end of the threaded hook bolt for installation when the threaded hook bolt is passed through the bolt hole and optionally a washer. When the threaded hook bolt is installed, including passing a threaded end of the threaded hook bolt through the bolt hole and fastening with the nut, the hook engages the superstructure. The apparatus is installed from above the superstructure without drilling holes in ties or the superstructure, or requiring manned installation from below the superstructure.

Abstract: Described herein are compositions of an linoleic phospholipid for inhibiting inflammatory pathways or neurodegenerative processes. Also provided are uses of such compositions and methods of inhibiting inflammatory or neurodegenerative processes by administering a composition that includes an linoleic phospholipid and optionally a carrier to a cell, cell culture or subject in need of such treatment.

Abstract: Described herein are compositions of an linoleic phospholipid for inhibiting inflammatory pathways or neurodegenerative processes. Also provided are uses of such compositions and methods of inhibiting inflammatory or neurodegenerative processes by administering a composition that includes an linoleic phospholipid and optionally a carrier to a cell, cell culture or subject in need of such treatment.

Abstract: The present invention provides combinations of pharmaceutically active agents (i.e. statins and negatively charged phospholipids) for treating or preventing atherosclerosis or coronary artery disease (CAD) in mammals, and methods therefore. In particular, these combinations and methods find utility for achieving one or more of the following effects in a subject: (1) a reduction in plasma levels of low-density lipoprotein (LDL) cholesterol and very-low-density lipoprotein (VLDL) cholesterol; (2) an increase in plasma levels of high-density lipoprotein (HDL) cholesterol; and (3) a reduction in plasma levels of triglycerides.

Abstract: The present invention provides pharmaceutical compositions and methods for raising plasma levels of apolipoprotein A-I in a mammal, e.g. for treating or preventing coronary artery disease (CAD). The inventive pharmaceutical compositions comprise: (a) a negatively charged phospholipid; and (b) at least one intestinal absorption enhancer; where (a) and (b) are present in such composition in amounts that render the combination effective for raising plasma levels of apolipoprotein A-I in a mammal. Also provided are corresponding methods of medical treatment comprising administering to a mammal: (a) a negatively charged phospholipid; and (b) at least one intestinal absorption enhancer; where (a) and (b) are administered in amounts that render the combination effective for raising plasma levels of apolipoprotein A-I in said mammal.

Abstract: The invention provides a pharmaceutical composition comprising a synthetic or naturally occurring charged phospholipid, which is formulated into a dosage form for administration to a subject or which is administered as a food additive. Negatively charged phospholipid composition increase the net negative charge on intravascular lipoproteins, enhance the clearance of cholesterol and regulate the function of lipolytic enzymes, retard prothrombin formation and aid in the clearance of virus and bacterial particles. Negatively charged lipid compositions can therefore be administered to humans and animals for the treatment of hyperlipidemia and blood coagulation disorders and to reduce the levels of virus, bacteria, and endotoxins in the blood stream. Positively charged lipid compositions can be administered to delay lipoprotein clearance from the plasma compartment and give longer duration of activity for drugs which are associated with lipoproteins.

Abstract: The invention provides a pharmaceutical composition comprising a synthetic or naturally occurring charged phospholipid, which is formulated into a dosage form for administration to a subject or which is administered as a food additive. Negatively charged phospholipid composition increase the net negative charge on intravascular lipoproteins, enhance the clearance of cholesterol and regulate the function of lipolytic enzymes, retard prothrombin formation and aid in the clearance of virus and bacterial particles. Negatively charged lipid compositions can therefore be administered to humans and animals for the treatment of hyperlipidemia and blood coagulation disorders and to reduce the levels of virus, bacteria, and endotoxins in the blood stream. Positively charged lipid compositions can be administered to delay lipoprotein clearance from the plasma compartment and give longer duration of activity for drugs which are associated with lipoproteins.